NASS 2017 Annual Meeting

Jeffrey Lotz, PhD




Royalties: University of California (B); Stock Ownership: ISTO Technologies (<1%), Relievant Med Systems (<1%), Nocimed (9%), Simpirica (<1%), Aleeva Medical (<1%), SMC Biotech (<1%); Private Investments: Nocimed (<1%); Consulting: Applied Biomechanics (Amount not disclosed); Scientific Advisory Board: Relievant (Amount not disclosed), SMC Biotech (Amount not disclosed); Research Support - Investigator Salary: Orthofix (B, Paid directly to institution/employer); Research Support - Staff and/or Materials: Orthofix (E, Paid directly to institution/employer); Grants: Orthofix (E, Paid directly to institution/employer).

Sessions :